The Journal of Organic Chemistry
Article
Afterward the solution was concentrated, under reduced pressure, and
applied to the top of a silica gel (15 g) chromatography column,
equilibrated in CH2Cl2. The column was eluted with a linear gradient
of CH2Cl2 (100%) to CH2Cl2: MeOH (95:5) to afford pure 5 (129
[N-methyl-N-(4-nitro-2-pyridyl-N-oxide)amino]-1-phenylethanol (0.3
mmol, 86.73 mg) with 77% (139 mg) yield following general
1
procedure B. H NMR (400 MHz, DMSO-d6) δ (ppm) 8.26 (d, J =
7.2, 1H), 7.64 (m, J = 7.2, 1H), 7.56 (dd, 1H), 7.35 (m, 6H), 6.16 (m,
1H), 5.93 (m, 1H), 5.09 (m, 1H), 4.35 (m, 1H), 4.23 (m, 2H), 4.05
(m, 1H), 3.9 (m, 1H), 3.08 (s, 3H), 2.30 (m, 2H), 2.1 (m, 3H), 1.74
(dd, J = 1.2, 7.0, 3H). 13C NMR (100 MHz, DMSO-d6) δ (ppm)
170.0, 163. 6, 159.3, 155.2, 153.6, 150.4, 142.6, 140.7, 137.3, 135.7,
128.5, 128.3, 126.1, 110.9, 109.9, 108.7, 84.0, 83.6, 80.8, 78.2, 74.7,
73.4, 67.2, 53.9, 35.4, 20.7, 12.0. HRMS (ESI-q-TOF) m/z: [M + H]+
calcd. for C27H30N5O11 600.1942; found 600.1939.
1
mg, 80%). H NMR (500 MHz, DMSO-d6) δ (ppm) 11.36 (s, 1H),
8.37 (d, J = 5.4 Hz, 1H), 7.46 (s, 1H), 7.36 (s, 1H), 7.31 (t, J = 7.4 Hz,
2H), 7.26−7.21 (m, 5H), 6.16 (dd, J = 8.0, 6.5 Hz, 1H), 5.16−5.15
(m, 1H), 4.86 (s, 2H), 4.38−4.30 (m, 2H), 4.13 (dd, J = 7.6, 4.6 Hz,
1H), 3.96 (t, J = 5.3 Hz, 2H), 2.36−2.31 (m, 1H), 2.26 (ddd, J = 14.2,
6.1, 2.4 Hz, 1H), 2.06 (s, 3H), 1.73 (s, 3H). 13C NMR (125 MHz,
DMSO-d6) δ (ppm) 169.9, 163.5, 159.2, 155.3, 154.2, 150.3, 137.6,
135.6, 128.6, 128.3, 127.0, 126.5, 109.9, 104.1, 98.7, 84.0, 80.8, 73.6,
67.2, 65.5, 51.5, 47.0, 35.4, 20.7, 12.0. HRMS (ESI-q-TOF) m/z: [M
+ H]+ calcd. for C27H30N5O10 584.1993; found 584.1984.
General Procedure (B) for Generating of the Reducing
Agent. Anhydrous tetrahydrofuran was placed in a two-neck round-
bottom flask and cooled to 0 °C in water/ice bath. Then the titanium
tetrachloride (0.5 mmol, 55 μL) was added portionwise and kept for
10 min at room temperature. Lithium aluminum hydride (0.35 mmol,
13 mg) was added portionwise, and the resulting black slurry was
stirred in inert atmosphere, at room temperature for 15 min (TiCl4/
LiAlH4 − 1/0.8).
General Procedure for N-Protected-3′-O-acetyl-5′-(N-meth-
yl-(4-aminopyridin-2-yl)]aminoethyloxycarbonyl Nucleosides
(6−10). Compounds (1−4) (0.1 mmol), diluted in a anhydrous
THF, was added portionwise at 0 °C to the stirred black slurry of
titanium reagent. The reaction mixture was stirred at room
temperature for 15−30 min, until the starting material was not
observed by TLC. Traces of LiAlH4 were decomposed with water, the
black slurry was centrifuged, and the solution was flushed through thin
layer of silica gel (DCM/MeOH 95:5).
8-Amino-1-methyl-3-phenyl-2,3-dihydro-1H-pyrido[1,2-b][1,2,4]-
oxadiazin-5-ium Chloride (13). HRMS (ESI-q-TOF) m/z: [M]+
calcd. for C14H16N3O+ 242.1288; found 242.1309.
7-Amino-1-methyl-3-phenyl-2,3-dihydro-1H-imidazo[1,2-a]-
1
pyridin-4-ium Chloride (14). H NMR (400 MHz, DMSO) δ (ppm)
7.71 (s, 2H), 7.47−7.35 (m, 5H), 6.18 (d, J = 7.2 Hz, 1H), 5.91 (s,
1H), 5.72 (dd, J = 9.3, 6.8, 1H), 4.17 (t = , J = 9.7 Hz, 1H), 3.67 (dd, J
= 9.8, 6.7 Hz, 2H), 2.96 (s, 3H). HRMS (ESI-q-TOF) m/z: [M]+
+
calcd. for C14H16N3 226.1339; found 226.1339.
ASSOCIATED CONTENT
* Supporting Information
The Supporting Information is available free of charge on the
■
S
Materials, general methods, characterization of depro-
tection rates and NMR and HRMS data (PDF)
AUTHOR INFORMATION
Corresponding Author
(M.K.C.).
■
3′-O-acetyl-5′-O-[2-N-methyl-N-(4-aminopyridin-2-yl)]amino-1-
phenylethyloxycarbonyl-thymidine (6). Compound 1 was trans-
formed into compound 6 with 68% (38 mg) yield following general
procedure B. 1H NMR (400 MHz, DMSO) δ (ppm) 11.34 (d, J = 6.8,
1H), 11.03 (bs, 2H), 8.92 (d, J = 5.4, 1H), 8.13−8.09 (m, 1H), 7.53
(d, J = 3, 1H), 7.36−7.28 (m, 6H), 6.08 (dd, J = 12.3, 6.1, 1H), 5.84−
5.79 (m, 1H), 5.02 (dd, J = 16.1, 6.5, 1H), 4.27−4.04 (m, 5H), 2.41−
2.29 (m, 1H), 2.16−2.14 (m, 1H), 1.98 (d, J = 1.8, 3H), 1.66 (s, 3H),
1.22 (d, J = 6.4, 3H). 13C NMR (100 MHz, DMSO-d6) δ (ppm) 12.5,
21.2, 35.8, 37.8, 54.7, 67.6, 73.8, 78.1, 81.3, 84.5, 99.0, 104.2, 110.4,
126.9, 18.1, 129.0, 137.8, 136.4, 141.7, 146.3, 150.8, 155.6, 159.6,
164.1, 170.4. HRMS (ESI-q-TOF) m/z: [M + H]+ calcd. for
C27H32N5O8; 554.2251, found 554.2250.
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
We would like to thank Professor Jacek Stawin
■
ski (IChB PAS)
for reading this manuscript and for his helpful suggestions. This
research was supported by the European Regional Develop-
ment Fund within the Innovative Economy Program (Grant
No. POIG.01.03.01-30-045). This publication was supported
by the Polish Ministry of Science and Higher Education, under
the KNOW program.
N4-Benzoyl-3′-O-acetyl-5′-O-[2-N-methyl-N-(4-aminopyridin-2-
yl)]amino-1-phenylethyloxycarbonyl-2′-deoksycytidine (7). Com-
pound 2 was transformed into compound 7 following general
procedure B. HRMS (ESI-q-TOF) m/z: [M + H]+ calcd. for
C33H35N6O8; 643.2516; found 643.2517.
REFERENCES
■
(1) Keasling, J. D. ACS Chem. Biol. 2008, 3, 64−76.
(2) Grajkowski, A.; Pedras-Vasconcelos, J.; Wang, V. V.; Ausin, C.;
Hess, S.; Verthelyi, D.; Beaucage, S. L. Nucleic Acids Res. 2005, 33,
3550−3560.
(3) Lebedev, A. V.; Paul, N.; Yee, J.; Timoshchuk, V. A.; Shum, J.;
Miyagi, K.; Kellum, J.; Hogrefe, R. I.; Zon, G. Nucleic Acids Res. 2008,
36, 131.
3′-O-acetyl-5′-O-[2-N-benzyl-N-(4-aminopyridin-2-yl)]-
aminoethyloxycarbonyl-thymidine (10). Compound 5 (84 mg, 0.14
mmol) was reduced following the general procedure. To the obtained
precipitate free solution aq 12 M HCl (1 equiv) was added, and the
solvent was evaporated under reduced pressure. Crude product was
diluted in methanol, applied on the PLC and eluted with iPrOH: H2O
(7:3) at 4 °C to afford product 10 (58 mg, 74%). 1H NMR (500 MHz,
MeOd) δ (ppm) 7.45−7.44 (m, 1H), 7.32 (t, J = 7.5 Hz, 2H), 7.24(t, J
= 7.4 Hz, 1H), 7.17 (d, J = 7.2 Hz, 2H), 6.25 (dd, J = 7.2, 2.0 Hz, 1H),
6.18 (dd, J = 8.4, 5.9 Hz, 1H), 5.95 (d, J = 2.0 Hz, 1H), 5.17 (dt, J =
6.5, 2.3 Hz, 1H), 4.72 (s, 2H), 4.42−4.35 (m, 2H), 4.32 (dd, J = 11.8,
3.3 Hz, 2H), 4.20−4.18 (m, 1H), 3.85 (dd, J = 10.7, 5.7 Hz, 2H), 2.37
(ddd, J = 14.3, 5.9, 2.2 Hz, 1H), 2.29−2.26 (m, 1H), 2.06 (s, 3H), 2.00
(s, 3H). 13C NMR (100 MHz, MeOd) δ (ppm) 172.1, 166.2, 161.2,
156.0, 153.7, 152.2, 137.9, 137.3, 136.5, 130.1, 128.9, 127.4, 111.9,
104.3, 89.8, 86.7, 83.5, 75.6, 68.7, 62.9, 56.3, 54.2, 30.7, 20.9, 12.9.
HRMS (ESI-q-TOF) m/z: [M + H]+ calcd. for C27H32N5O8
554.2251, found 554.2245.
(4) Anastas, P. T.; Kirchhoff, M. M. Acc. Chem. Res. 2002, 35, 686−
694.
(5) (a) Wilk, A.; Grajkowski, A.; Philips, L. R.; Beaucage, S. L. J. Org.
Chem. 1999, 64, 7515−7522. (b) Prokopczyk, B.; Bertinato, P.;
Hoffman, D. Carcinogenesis 1988, 9, 2125−2128.
(6) (a) Wilk, A.; Chmielewski, M. K.; Grajkowski, A.; Phillips, L. R.;
Beaucage, S. L. Tetrahedron Lett. 2001, 42, 5635−5639. (b) Grajkow-
ski, A.; Wilk, A.; Chmielewski, M. K.; Phillips, L. R.; Beaucage, S. L.
Org. Lett. 2001, 3, 1287−1290. (c) Wilk, A.; Chmielewski, M. K.;
Grajkowski, A.; Phillips, L. R.; Beaucage, S. L. J. Org. Chem. 2002, 67,
6430−6438.
(7) (a) Ciesl
́
ak, J.; Grajkowski, A.; Livengood, V.; Beaucage, S. L. J.
O-5′-(3′-O-acetylthymidinylcarbonyloxy-1-phenylethyl)
(methyl)amino)-4-nitropyridine 1-Oxide (12). Compound 12 was
obtained from 3′-O-acetylthymidine (0.3 mmol, 87.9 mg) and ( )-2-
Org. Chem. 2004, 69, 2509−2515. (b) Kiuru, E.; Ahmed, Z.; Lonnberg,
H.; Beigelman, L.; Ora, M. J. Org. Chem. 2013, 78, 950−959.
̈
G
J. Org. Chem. XXXX, XXX, XXX−XXX